This article explores how challenges such as sequence optimization, immune activation and off-target effects are being ...

RNA technology has had its own Big Bang event. It occurred just a couple of years ago when, seemingly out of nothing, the mRNA-based COVID-19 vaccines appeared. Well, they only seemed to come out of ...

This work was supported by funding from New Zealand Ministry of Business Innovation and Employment, Research Trust of Victoria University of Wellington and The Hugh Green Foundation. The recent award ...

Researchers have captured the first detailed molecular snapshots of human polynucleotide phosphorylase (hPNPase) in action, ...

CEATEC 2025 featured the usual lineup of AI demos, service robots, and experimental interfaces. But inside Hall 4, a quieter, lab-style booth ...

Johns Hopkins University, home to considerable expertise in RNA sciences and therapeutic development, has announced a new academic collaboration with TriLink BioTechnologies, part of Maravai ...

The global RNA therapeutics and vaccines market size was valued at USD 0.21 billion in 2024 and is predicted to hit around ...

Penn Commons at the University of Pennsylvania (Mark Henninger/Imagic Digital) Cellular-level biology that could help develop vaccines just got more accessible to researchers, thanks to AI. The ...

PRQR, last year, failed a pivotal trial. This is the third time it has failed trials after showing early signs of efficacy. While they are making an effort, I see little future here. PRQR is a Dutch ...

< Photo 1. (From left) Professor Won Do Heo and Jihwan Yu, a Ph.D. Candidate of the Department of Biological Sciences > CRISPR-Cas13, a powerful RNA-targeting technology is gaining increasing ...

Renaissance BioScience’s novel RNA production and delivery technology receives Mexican patent: Vancouver, Canada Monday, December 8, 2025, 17:00 Hrs [IST] Renaissance BioScience ...